Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF (Site 1107)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Colorectal cancer

Closed trials

• Completed

  Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

  NCT04776148· Phase 3· Merck Sharp & Dohme LLC· Source